Rxivist logo

A human monoclonal 1 antibody blocking SARS-CoV-2 infection

By Chunyan Wang, Wentao Li, Dubravka Drabek, Nisreen M.A. Okba, Rien van Haperen, Albert D.M.E. Osterhaus, Frank J.M. van Kuppeveld, Bart L. Haagmans, Frank Grosveld, Berend-Jan Bosch

Posted 12 Mar 2020
bioRxiv DOI: 10.1101/2020.03.11.987958 (published DOI: 10.1038/s41467-020-16256-y)

The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV). This cross-neutralizing antibody targets a communal epitope on these viruses and offers potential for prevention and treatment of COVID-19.

Download data

  • Downloaded 103,485 times
  • Download rankings, all-time:
    • Site-wide: 8 out of 106,159
    • In microbiology: 2 out of 9,238
  • Year to date:
    • Site-wide: 5 out of 106,159
  • Since beginning of last month:
    • Site-wide: 273 out of 106,159

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)